Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis
2008 ◽
Vol 155
(5)
◽
pp. 791-805
◽
2020 ◽
Vol 43
(7)
◽
pp. 959-972
◽
2015 ◽
Vol 349
(6)
◽
pp. 510-515
◽
Keyword(s):
2016 ◽
Vol 67
(5)
◽
pp. 728-741
◽